| For: |
Zang JJ, Xie F, Xu JF, Qin YY, Shen RX, Yang JM, He J. |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i25/3043.htm |
| Number | Citing Articles |
| 1 |
Ze-Guang Han. Functional Genomic Studies: Insights into the Pathogenesis of Liver Cancer. Annual Review of Genomics and Human Genetics 2012; 13(1) doi: 10.1146/annurev-genom-090711-163752
|
| 2 |
Tatsuhiro Shibata, Hiroyuki Aburatani. Exploration of liver cancer genomes. Nature Reviews Gastroenterology & Hepatology 2014; 11(6) doi: 10.1038/nrgastro.2014.6
|
| 3 |
Sadiya Sadiq Shiek, Monica Shirley Mani, Shama Prasada Kabekkodu, Herman S. Dsouza. Health repercussions of environmental exposure to lead: Methylation perspective. Toxicology 2021; 461 doi: 10.1016/j.tox.2021.152927
|
| 4 |
Yu Guo, Jing Wang, Hua Li, Wei Liu, Dong Chen, Kun Zhao, Xinjun Liang, Qi Zhang, Yang Yang, Guihua Chen. Mediator subunit 23 overexpression as a novel target for suppressing proliferation and tumorigenesis in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2015; 30(6) doi: 10.1111/jgh.12923
|
| 5 |
Eva Juárez-Hernández, Daniel Motola-Kuba, Norberto Carlos Chávez-Tapia, Misael Uribe, Varenka Barbero Becerra. Biomarkers in hepatocellular carcinoma: an overview. Expert Review of Gastroenterology & Hepatology 2017; 11(6) doi: 10.1080/17474124.2017.1311785
|
| 6 |
Guillaume Vares, Bing Wang, Hiroko Ishii-Ohba, Mitsuru Nenoi, Tetsuo Nakajima, Sonia Rocha. Diet-Induced Obesity Modulates Epigenetic Responses to Ionizing Radiation in Mice. PLoS ONE 2014; 9(8) doi: 10.1371/journal.pone.0106277
|
| 7 |
Patrick Reichl, Wolfgang Mikulits. Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review). Oncology Reports 2016; 36(2) doi: 10.3892/or.2016.4842
|
| 8 |
Ganganapalli Supraja, Kalisetty Chengaiahgari Maheswari, Deepika Pamarthy, Kallimakula Venkata Reddy Saritha. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; doi: 10.1016/B978-0-323-99283-1.00006-9
|
| 9 |
Helmut Denk, Peter M. Abuja, Kurt Zatloukal. Mallory-Denk bodies and hepatocellular senescence: a causal relationship?. Virchows Archiv 2024; 484(4) doi: 10.1007/s00428-024-03748-1
|
| 10 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; doi: 10.1007/978-3-319-26587-2_168-1
|
| 11 |
Xueyou Lv, Guoliang Ye, Xinjun Zhang, Tao Huang. p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival. Medicine 2017; 96(38) doi: 10.1097/MD.0000000000008106
|
| 12 |
Xian-Yang Qin, Tomokazu Fukuda, Linqing Yang, Hiroko Zaha, Hiromi Akanuma, Qin Zeng, Jun Yoshinaga, Hideko Sone. Effects of bisphenol A exposure on the proliferation and senescence of normal human mammary epithelial cells. Cancer Biology & Therapy 2012; 13(5) doi: 10.4161/cbt.18942
|
| 13 |
Debolina Pal, Subhayan Sur, Suvra Mandal, Ashes Das, Anup Roy, Sukta Das, Chinmay Kumar Panda. Prevention of liver carcinogenesis by amarogentin through modulation of G 1 /S cell cycle check point and induction of apoptosis. Carcinogenesis 2012; 33(12) doi: 10.1093/carcin/bgs276
|
| 14 |
Robyn P. Strauss, Katherine M. Audsley, Adam M. Passman, Joanne H. van Vuuren, Megan L. Finch-Edmondson, Bernard A. Callus, George C. Yeoh. Loss of ARF/INK4A Promotes Liver Progenitor Cell Transformation Toward Tumorigenicity Supporting Their Role in Hepatocarcinogenesis. Gene Expression 2020; 20(1) doi: 10.3727/105221620X15874935364268
|
| 15 |
Xiaotu Ma, Yi-Wei Wang, Michael Q Zhang, Adi F Gazdar. DNA Methylation Data Analysis and its Application to Cancer Research. Epigenomics 2013; 5(3) doi: 10.2217/epi.13.26
|
| 16 |
Markênia Kélia Santos Alves, Mário Henrique Girão Faria, Eduardo Henrique Cunha Neves Filho, Adriana Camargo Ferrasi, Maria Inês de Moura Campos Pardini, Manoel Odorico de Moraes Filho, Silvia Helena Barem Rabenhorst. CDKN2A promoter hypermethylation in astrocytomas is associated with age and sex. International Journal of Surgery 2013; 11(7) doi: 10.1016/j.ijsu.2013.05.030
|
| 17 |
Hasan Safwan-Zaiter, Nicole Wagner, Kay-Dietrich Wagner. P16INK4A—More Than a Senescence Marker. Life 2022; 12(9) doi: 10.3390/life12091332
|
| 18 |
Maria A. Livrea, Luisa Tesoriere. Pigments in Fruits and Vegetables. 2015; doi: 10.1007/978-1-4939-2356-4_7
|
| 19 |
Dorcas Ibukun Akinloye, Olatunbosun Samuel Sojinu, Regina Ngozi Ugbaja, Samuel Agemo, Moses Oluwasegun Akintubuwa, Tolulope Julius Bolaji. Appraisal of Acalypha wilkesiana Godseffiana mitigating effects against carbon tetrachloride (CCl4)-induced oxidative impairment in female wistar rat. Advances in Traditional Medicine 2023; 23(2) doi: 10.1007/s13596-021-00588-1
|
| 20 |
Nikola Kokanov, Milena Krajnovic, Snezana Cupic-Jovanovic, Bojana Kozik, Nina Petrovic, Ana Bozovic, Vesna Mandusic. RASSF1A and p16 promoter methylation and treatment response in chronic hepatitis C genotype 1b patients treated with pegylated interferon/ribavirin. Archives of Biological Sciences 2022; 74(1) doi: 10.2298/ABS211208004K
|
| 21 |
Wenrui Ye, Stefan Siwko, Robert Y. L. Tsai. Sex and Race-Related DNA Methylation Changes in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(8) doi: 10.3390/ijms22083820
|
| 22 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; doi: 10.1007/978-3-319-26956-6_168
|
| 23 |
Hoang Van Tong, Pham Van Dung, Nguyen Thi Mong Diep, Nguyen Linh Toan. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.98483
|
| 24 |
Jaroslaw Cisowski, Ahmed Ezat El Zowalaty, Sama I. Sayin, Piotr Czarnota, Tomasz Gromowski, Ella A. Eklund, Muhammad Kashif, Angana A. H. Patel, Antonio Molinaro, Per Lindahl, Clotilde Wiel, Volkan I. Sayin, Martin O. Bergo.
BRAF inhibition increases TGFβ2 production and stimulates metastasis in mice with endogenous BRAF
V600E
-induced hepatocellular carcinoma
. Proceedings of the National Academy of Sciences 2025; 122(45) doi: 10.1073/pnas.2503044122
|
| 25 |
Deniz Tümen, Philipp Heumann, Karsten Gülow, Cagla-Nur Demirci, Lidia-Sabina Cosma, Martina Müller, Arne Kandulski. Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma. Biomedicines 2022; 10(12) doi: 10.3390/biomedicines10123202
|
| 26 |
Lichun Qiao, Xuan Liu, Yujie He, Jiaheng Zhang, Hao Huang, Wenming Bian, Mumba Mulutula Chilufya, Yan Zhao, Jing Han. Progress of Signaling Pathways, Stress Pathways and Epigenetics in the Pathogenesis of Skeletal Fluorosis. International Journal of Molecular Sciences 2021; 22(21) doi: 10.3390/ijms222111932
|
| 27 |
Pin Zhao, Samiullah Malik, Shaojun Xing. Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC). Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.677926
|
| 28 |
Shouli Wu, Weimin Yan, Bing Qiu, Yongfang Liao, Junying Gu, Shaofeng Wei, Aihua Zhang, Xueli Pan. Aberrant methylation‐induced dysfunction of p16 is associated with osteoblast activation caused by fluoride. Environmental Toxicology 2019; 34(1) doi: 10.1002/tox.22655
|
| 29 |
Song Zhang, Ying Zhou, Yanan Wang, Zhengwen Wang, Qitao Xiao, Ying Zhang, Yan Lou, Yunqing Qiu, Feng Zhu. The mechanistic, diagnostic and therapeutic novel nucleic acids for hepatocellular carcinoma emerging in past score years. Briefings in Bioinformatics 2021; 22(2) doi: 10.1093/bib/bbaa023
|
| 30 |
Hongqiao Cai, Xiaocheng Li, Yahui Liu, Jianji Ke, Kaiyu Liu, Yixin Xie, Cheng Xie, Dan Zhou, Mingda Han, Bai Ji. Decitabine-based nanoparticles for enhanced immunotherapy of hepatocellular carcinoma via DNA hypermethylation reversal. Chemical Engineering Journal 2024; 492 doi: 10.1016/j.cej.2024.152175
|
| 31 |
Annabelle L. Fonseca, Johan Kugelberg, Lee F. Starker, Ute Scholl, Murim Choi, Per Hellman, Göran Åkerström, Gunnar Westin, Richard P. Lifton, Peyman Björklund, Tobias Carling. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors. Genes, Chromosomes and Cancer 2012; 51(10) doi: 10.1002/gcc.21978
|
| 32 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; doi: 10.1007/978-3-319-26956-6_174
|
| 33 |
Wael Abd Elgwad Elsewify, Elham Ahmed Hassan, Mohamed A Mekky, Abeer Sharaf El-Din Abd El-Rehim, Zain El-Abdeen Ahmed Sayed, Mohamed Omar Abdel Malek, Tarek TH ElMelegy, Abeer Sabry. <p>Usefulness of Circulating Methylated p16 as a Noninvasive Molecular Biomarker for Hepatitis C-Related Hepatocellular Carcinoma with Normal Serum Alpha-Fetoprotein Levels</p>. International Journal of General Medicine 2020; doi: 10.2147/IJGM.S249272
|
| 34 |
Debolina Pal, Subhayan Sur, Rituparna Roy, Suvra Mandal, Chinmay Kumar Panda. Hypomethylation of LIMD1 and P16 by downregulation of DNMT1 results in restriction of liver carcinogenesis by amarogentin treatment. Journal of Biosciences 2021; 46(3) doi: 10.1007/s12038-021-00176-0
|
| 35 |
Tingting Fang, Li Feng, Jinglin Xia. Application of Clinical Bioinformatics. Translational Bioinformatics 2016; 11 doi: 10.1007/978-94-017-7543-4_16
|
| 36 |
Nikola Kokanov, Snezana Jovanovic-Cupic, Marina Siljic, Valentina Cirkovic, Nina Petrovic, Bojana Kozik, Milena Krajnovic. Variability of the HCV core region and host genetic and epigenetic factors can predict the response to pegylated interferon/ribavirin therapy in genotype 1b hepatitis C patients from Serbia. Archives of Biological Sciences 2023; 75(3) doi: 10.2298/ABS230316020K
|
| 37 |
Miner Hu, Xiaojun Xia, Lichao Chen, Yunpeng Jin, Zhenhua Hu, Shudong Xia, Xudong Yao. Emerging biomolecules for practical theranostics of liver hepatocellular carcinoma. Annals of Hepatology 2023; 28(6) doi: 10.1016/j.aohep.2023.101137
|
| 38 |
CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2018; 42(6) doi: 10.1016/j.clinre.2017.07.003
|
| 39 |
Hui Zhang, Wanpin Nie, Feizhou Huang. The Correlation Relationship between P14ARF Gene DNA Methylation and Primary Liver Cancer. Medical Science Monitor 2015; 21 doi: 10.12659/MSM.894395
|
| 40 |
Yangchun Xu, Litong Gu, Jiaxin Wang, Zhenqi Wang, Ping Zhang, Xuan Zhang. Detection of Circulating Antibodies to p16 Protein-Derived Peptides in Hepatocellular Carcinoma. Laboratory Medicine 2020; 51(6) doi: 10.1093/labmed/lmaa006
|
| 41 |
Jason Brocato, Max Costa. Basic mechanics of DNA methylation and the unique landscape of the DNA methylome in metal-induced carcinogenesis. Critical Reviews in Toxicology 2013; 43(6) doi: 10.3109/10408444.2013.794769
|
| 42 |
Medine Zeynep Gungor, Merve Uysal, Mehmet Ozturk, Serif Senturk. Systematic Analysis of Cytostatic TGF-Beta Response in Mesenchymal-Like Hepatocellular Carcinoma Cell Lines. Journal of Gastrointestinal Cancer 2021; 52(4) doi: 10.1007/s12029-021-00704-z
|
| 43 |
Yasunobu Matsuda, Toshifumi Wakai, Masayuki Kubota, Masaaki Takamura, Satoshi Yamagiwa, Yutaka Aoyagi, Mami Osawa, Shun Fujimaki, Ayumi Sanpei, Takuya Genda, Takafumi Ichida. Clinical significance of cell cycle inhibitors in hepatocellular carcinoma. Medical Molecular Morphology 2013; 46(4) doi: 10.1007/s00795-013-0047-7
|
| 44 |
Bixian Luo, Jianwei Lin, Anqi Ni, Wei Cai, Xinbo Yu, Mingliang Wang. A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.927028
|
| 45 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; doi: 10.1007/978-3-319-26587-2_174-1
|
| 46 |
Emmanouil Bouras, Meropi Karakioulaki, Konstantinos I. Bougioukas, Michalis Aivaliotis, Georgios Tzimagiorgis, Michael Chourdakis. Gene promoter methylation and cancer: An umbrella review. Gene 2019; 710 doi: 10.1016/j.gene.2019.06.023
|